Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 42 entries
Sorted by: Best Match Show Resources per page
Familial hemiplegic migraine treated by sodium valproate and lamotrigine.

Cephalalgia : an international journal of headache

Pelzer N, Stam AH, Carpay JA, Vries BD, van den Maagdenberg AM, Ferrari MD, Haan J, Terwindt GM.
PMID: 24443394
Cephalalgia. 2014 Aug;34(9):708-711. doi: 10.1177/0333102413520086. Epub 2014 Jan 17.

BACKGROUND: Familial hemiplegic migraine (FHM) is a rare monogenic subtype of migraine with aura that includes motor auras. Prophylactic treatment of FHM often has marginal effects and involves a trial-and-error strategy based on therapeutic guidelines for non-hemiplegic migraine and...

Cite
Pelzer N, Stam AH, Carpay JA, et al. Familial hemiplegic migraine treated by sodium valproate and lamotrigine. Cephalalgia. 2014;34(9):708-711doi: 10.1177/0333102413520086.
Pelzer, N., Stam, A. H., Carpay, J. A., Vries, B. D., van den Maagdenberg, A. M., Ferrari, M. D., Haan, J., & Terwindt, G. M. (2014). Familial hemiplegic migraine treated by sodium valproate and lamotrigine. Cephalalgia : an international journal of headache, 34(9), 708-711. https://doi.org/10.1177/0333102413520086
Pelzer, Nadine, et al. "Familial hemiplegic migraine treated by sodium valproate and lamotrigine." Cephalalgia : an international journal of headache vol. 34,9 (2014): 708-711. doi: https://doi.org/10.1177/0333102413520086
Pelzer N, Stam AH, Carpay JA, Vries BD, van den Maagdenberg AM, Ferrari MD, Haan J, Terwindt GM. Familial hemiplegic migraine treated by sodium valproate and lamotrigine. Cephalalgia. 2014 Aug;34(9):708-711. doi: 10.1177/0333102413520086. Epub 2014 Jan 17. PMID: 24443394.
Copy Download .nbib Format: NLM
Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling.

Metabolomics : Official journal of the Metabolomic Society

Noga MJ, Zielman R, van Dongen RM, Bos S, Harms A, Terwindt GM, van den Maagdenberg AMJM, Hankemeier T, Ferrari MD.
PMID: 29527143
Metabolomics. 2018;14(4):44. doi: 10.1007/s11306-018-1333-0. Epub 2018 Mar 05.

INTRODUCTION: Metabolic profiling of cerebrospinal fluid (CSF) is a promising technique for studying brain diseases. Measurements should reflect the in vivo situation, so ex vivo metabolism should be avoided.OBJECTIVE: To investigate the effects of temperature (room temperature vs. 4...

Cite
Noga MJ, Zielman R, van Dongen RM, et al. Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling. Metabolomics. 2018;14(4):44doi: 10.1007/s11306-018-1333-0.
Noga, M. J., Zielman, R., van Dongen, R. M., Bos, S., Harms, A., Terwindt, G. M., van den Maagdenberg, A. M. J. M., Hankemeier, T., & Ferrari, M. D. (2018). Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling. Metabolomics : Official journal of the Metabolomic Society, 14(4), 44. https://doi.org/10.1007/s11306-018-1333-0
Noga, Marek J, et al. "Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling." Metabolomics : Official journal of the Metabolomic Society vol. 14,4 (2018): 44. doi: https://doi.org/10.1007/s11306-018-1333-0
Noga MJ, Zielman R, van Dongen RM, Bos S, Harms A, Terwindt GM, van den Maagdenberg AMJM, Hankemeier T, Ferrari MD. Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling. Metabolomics. 2018;14(4):44. doi: 10.1007/s11306-018-1333-0. Epub 2018 Mar 05. PMID: 29527143; PMCID: PMC5838118.
Copy Download .nbib Format: NLM
TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features.

American journal of kidney diseases : the official journal of the National Kidney Foundation

de Boer I, van den Maagdenberg AMJM, Terwindt GM.
PMID: 30846258
Am J Kidney Dis. 2019 Jun;73(6):893. doi: 10.1053/j.ajkd.2018.12.041. Epub 2019 Mar 04.

No abstract available.

Cite
de Boer I, van den Maagdenberg AMJM, Terwindt GM. TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features. Am J Kidney Dis. 2019;73(6):893doi: 10.1053/j.ajkd.2018.12.041.
de Boer, I., van den Maagdenberg, A. M. J. M., & Terwindt, G. M. (2019). TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features. American journal of kidney diseases : the official journal of the National Kidney Foundation, 73(6), 893. https://doi.org/10.1053/j.ajkd.2018.12.041
de Boer, Irene, et al. "TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features." American journal of kidney diseases : the official journal of the National Kidney Foundation vol. 73,6 (2019): 893. doi: https://doi.org/10.1053/j.ajkd.2018.12.041
de Boer I, van den Maagdenberg AMJM, Terwindt GM. TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features. Am J Kidney Dis. 2019 Jun;73(6):893. doi: 10.1053/j.ajkd.2018.12.041. Epub 2019 Mar 04. PMID: 30846258.
Copy Download .nbib Format: NLM
The potential danger of blocking CGRP for treating migraine in CADASIL patients.

Cephalalgia : an international journal of headache

de Boer I, MaassenVanDenBrink A, Terwindt GM.
PMID: 32660269
Cephalalgia. 2020 Dec;40(14):1676-1678. doi: 10.1177/0333102420941814. Epub 2020 Jul 13.

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited small vessel disease characterised by recurrent ischemic stroke, cognitive decline progressing to dementia, psychiatric disturbances and apathy. More than half of mutation carriers suffer from migraine,...

Cite
de Boer I, MaassenVanDenBrink A, Terwindt GM. The potential danger of blocking CGRP for treating migraine in CADASIL patients. Cephalalgia. 2020;40(14):1676-1678doi: 10.1177/0333102420941814.
de Boer, I., MaassenVanDenBrink, A., & Terwindt, G. M. (2020). The potential danger of blocking CGRP for treating migraine in CADASIL patients. Cephalalgia : an international journal of headache, 40(14), 1676-1678. https://doi.org/10.1177/0333102420941814
de Boer, Irene, et al. "The potential danger of blocking CGRP for treating migraine in CADASIL patients." Cephalalgia : an international journal of headache vol. 40,14 (2020): 1676-1678. doi: https://doi.org/10.1177/0333102420941814
de Boer I, MaassenVanDenBrink A, Terwindt GM. The potential danger of blocking CGRP for treating migraine in CADASIL patients. Cephalalgia. 2020 Dec;40(14):1676-1678. doi: 10.1177/0333102420941814. Epub 2020 Jul 13. PMID: 32660269; PMCID: PMC7691636.
Copy Download .nbib Format: NLM
Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study.

The journal of headache and pain

Verhagen IE, Brandt RB, Kruitbosch CMA, MaassenVanDenBrink A, Fronczek R, Terwindt GM.
PMID: 34753424
J Headache Pain. 2021 Nov 09;22(1):135. doi: 10.1186/s10194-021-01346-z.

No abstract available.

Cite
Verhagen IE, Brandt RB, Kruitbosch CMA, et al. Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study. J Headache Pain. 2021;22(1):135doi: 10.1186/s10194-021-01346-z.
Verhagen, I. E., Brandt, R. B., Kruitbosch, C. M. A., MaassenVanDenBrink, A., Fronczek, R., & Terwindt, G. M. (2021). Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study. The journal of headache and pain, 22(1), 135. https://doi.org/10.1186/s10194-021-01346-z
Verhagen, Iris E, et al. "Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study." The journal of headache and pain vol. 22,1 (2021): 135. doi: https://doi.org/10.1186/s10194-021-01346-z
Verhagen IE, Brandt RB, Kruitbosch CMA, MaassenVanDenBrink A, Fronczek R, Terwindt GM. Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study. J Headache Pain. 2021 Nov 09;22(1):135. doi: 10.1186/s10194-021-01346-z. PMID: 34753424; PMCID: PMC8577000.
Copy Download .nbib Format: NLM
The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects.

Science advances

Coll-Tané M, Gong NN, Belfer SJ, van Renssen LV, Kurtz-Nelson EC, Szuperak M, Eidhof I, van Reijmersdal B, Terwindt I, Durkin J, Verheij MMM, Kim CN, Hudac CM, Nowakowski TJ, Bernier RA, Pillen S, Earl RK, Eichler EE, Kleefstra T, Kayser MS, Schenck A.
PMID: 34088660
Sci Adv. 2021 Jun 04;7(23). doi: 10.1126/sciadv.abe2626. Print 2021 Jun.

Sleep disturbances in autism and neurodevelopmental disorders are common and adversely affect patient's quality of life, yet the underlying mechanisms are understudied. We found that individuals with mutations in

Cite
Coll-Tané M, Gong NN, Belfer SJ, et al. The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects. Sci Adv. 2021;7(23)doi: 10.1126/sciadv.abe2626.
Coll-Tané, M., Gong, N. N., Belfer, S. J., van Renssen, L. V., Kurtz-Nelson, E. C., Szuperak, M., Eidhof, I., van Reijmersdal, B., Terwindt, I., Durkin, J., Verheij, M. M. M., Kim, C. N., Hudac, C. M., Nowakowski, T. J., Bernier, R. A., Pillen, S., Earl, R. K., Eichler, E. E., Kleefstra, T., Kayser, M. S., & Schenck, A. (2021). The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects. Science advances, 7(23), . https://doi.org/10.1126/sciadv.abe2626
Coll-Tané, Mireia, et al. "The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects." Science advances vol. 7,23 (2021). doi: https://doi.org/10.1126/sciadv.abe2626
Coll-Tané M, Gong NN, Belfer SJ, van Renssen LV, Kurtz-Nelson EC, Szuperak M, Eidhof I, van Reijmersdal B, Terwindt I, Durkin J, Verheij MMM, Kim CN, Hudac CM, Nowakowski TJ, Bernier RA, Pillen S, Earl RK, Eichler EE, Kleefstra T, Kayser MS, Schenck A. The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects. Sci Adv. 2021 Jun 04;7(23). doi: 10.1126/sciadv.abe2626. Print 2021 Jun. PMID: 34088660; PMCID: PMC8177706.
Copy Download .nbib Format: NLM
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study.

The journal of headache and pain

MaassenVanDenBrink A, Terwindt GM, Cohen JM, Barash S, Campos VR, Galic M, Ning X, Kärppä M.
PMID: 34922436
J Headache Pain. 2021 Dec 18;22(1):152. doi: 10.1186/s10194-021-01336-1.

BACKGROUND: Migraine prevalence is age and sex dependent, predominating in women in early and middle adulthood; however, migraine also represents a substantial burden for men and adults of all ages. Thus, understanding this burden and the efficacy of migraine...

Cite
MaassenVanDenBrink A, Terwindt GM, Cohen JM, et al. Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study. J Headache Pain. 2021;22(1):152doi: 10.1186/s10194-021-01336-1.
MaassenVanDenBrink, A., Terwindt, G. M., Cohen, J. M., Barash, S., Campos, V. R., Galic, M., Ning, X., & Kärppä, M. (2021). Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study. The journal of headache and pain, 22(1), 152. https://doi.org/10.1186/s10194-021-01336-1
MaassenVanDenBrink, Antoinette, et al. "Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study." The journal of headache and pain vol. 22,1 (2021): 152. doi: https://doi.org/10.1186/s10194-021-01336-1
MaassenVanDenBrink A, Terwindt GM, Cohen JM, Barash S, Campos VR, Galic M, Ning X, Kärppä M. Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study. J Headache Pain. 2021 Dec 18;22(1):152. doi: 10.1186/s10194-021-01336-1. PMID: 34922436.
Copy Download .nbib Format: NLM
The effect of needle size on cerebrospinal fluid collection time and post-dural puncture headache: A retrospective cohort study.

Headache

van Dongen RM, Onderwater GLJ, Pelzer N, Zielman R, van Oosterhout WPJ, van Zwet EW, Ferrari MD, Terwindt GM.
PMID: 33452678
Headache. 2021 Feb;61(2):329-334. doi: 10.1111/head.14046. Epub 2021 Jan 16.

OBJECTIVE: The main objective of this study was to compare cerebrospinal fluid (CSF) collection time and patient's discomfort between 20G (a)traumatic and 22G atraumatic needles.BACKGROUND: Risk of post-dural puncture headache (PDPH) is decreased using atraumatic needles. Smaller needles may...

Cite
van Dongen RM, Onderwater GLJ, Pelzer N, et al. The effect of needle size on cerebrospinal fluid collection time and post-dural puncture headache: A retrospective cohort study. Headache. 2021;61(2):329-334doi: 10.1111/head.14046.
van Dongen, R. M., Onderwater, G. L. J., Pelzer, N., Zielman, R., van Oosterhout, W. P. J., van Zwet, E. W., Ferrari, M. D., & Terwindt, G. M. (2021). The effect of needle size on cerebrospinal fluid collection time and post-dural puncture headache: A retrospective cohort study. Headache, 61(2), 329-334. https://doi.org/10.1111/head.14046
van Dongen, Robin M, et al. "The effect of needle size on cerebrospinal fluid collection time and post-dural puncture headache: A retrospective cohort study." Headache vol. 61,2 (2021): 329-334. doi: https://doi.org/10.1111/head.14046
van Dongen RM, Onderwater GLJ, Pelzer N, Zielman R, van Oosterhout WPJ, van Zwet EW, Ferrari MD, Terwindt GM. The effect of needle size on cerebrospinal fluid collection time and post-dural puncture headache: A retrospective cohort study. Headache. 2021 Feb;61(2):329-334. doi: 10.1111/head.14046. Epub 2021 Jan 16. PMID: 33452678; PMCID: PMC7985863.
Copy Download .nbib Format: NLM
Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic Review.

Neuropsychiatric disease and treatment

Monahan RC, Beaart HJL, Fronczek R, Terwindt GM, Beaart-van de Voorde LJJ, de Bresser J, Kloppenburg M, van der Wee NJA, Huizinga TWJ, Steup-Beekman GM.
PMID: 33376333
Neuropsychiatr Dis Treat. 2020 Dec 22;16:3173-3186. doi: 10.2147/NDT.S267000. eCollection 2020.

PURPOSE: To evaluate the use of immunosuppressive treatment, clinical outcome and diagnostic strategy in patients with systemic lupus erythematosus (SLE) presenting with clinical features of transverse myelitis (TM), but normal MRI of the spinal cord (sMRI) and normal cerebrospinal...

Cite
Monahan RC, Beaart HJL, Fronczek R, et al. Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic Review. Neuropsychiatr Dis Treat. 2020;16:3173-3186doi: 10.2147/NDT.S267000.
Monahan, R. C., Beaart, H. J. L., Fronczek, R., Terwindt, G. M., Beaart-van de Voorde, L. J. J., de Bresser, J., Kloppenburg, M., van der Wee, N. J. A., Huizinga, T. W. J., & Steup-Beekman, G. M. (2020). Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic Review. Neuropsychiatric disease and treatment, 163173-3186. https://doi.org/10.2147/NDT.S267000
Monahan, Rory C, et al. "Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic Review." Neuropsychiatric disease and treatment vol. 16 (2020): 3173-3186. doi: https://doi.org/10.2147/NDT.S267000
Monahan RC, Beaart HJL, Fronczek R, Terwindt GM, Beaart-van de Voorde LJJ, de Bresser J, Kloppenburg M, van der Wee NJA, Huizinga TWJ, Steup-Beekman GM. Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic Review. Neuropsychiatr Dis Treat. 2020 Dec 22;16:3173-3186. doi: 10.2147/NDT.S267000. eCollection 2020. PMID: 33376333; PMCID: PMC7764958.
Copy Download .nbib Format: NLM
Striped occipital cortex and intragyral hemorrhage: Novel magnetic resonance imaging markers for cerebral amyloid angiopathy.

International journal of stroke : official journal of the International Stroke Society

Koemans EA, Voigt S, Rasing I, Jolink W, van Harten TW, van der Grond J, van Rooden S, Schreuder F, Freeze WM, van Buchem MA, van Zwet EW, van Veluw SJ, Terwindt GM, van Osch M, Klijn C, van Walderveen M, Wermer M.
PMID: 33535905
Int J Stroke. 2021 Dec;16(9):1031-1038. doi: 10.1177/1747493021991961. Epub 2021 Feb 03.

BACKGROUND AND AIM: To investigate whether a striped occipital cortex and intragyral hemorrhage, two markers recently detected on ultra-high-field 7-tesla-magnetic resonance imaging in hereditary cerebral amyloid angiopathy (CAA), also occur in sporadic CAA (sCAA) or non-sCAA intracerebral hemorrhage (ICH).METHODS:...

Cite
Koemans EA, Voigt S, Rasing I, et al. Striped occipital cortex and intragyral hemorrhage: Novel magnetic resonance imaging markers for cerebral amyloid angiopathy. Int J Stroke. 2021;16(9):1031-1038doi: 10.1177/1747493021991961.
Koemans, E. A., Voigt, S., Rasing, I., Jolink, W., van Harten, T. W., van der Grond, J., van Rooden, S., Schreuder, F., Freeze, W. M., van Buchem, M. A., van Zwet, E. W., van Veluw, S. J., Terwindt, G. M., van Osch, M., Klijn, C., van Walderveen, M., & Wermer, M. (2021). Striped occipital cortex and intragyral hemorrhage: Novel magnetic resonance imaging markers for cerebral amyloid angiopathy. International journal of stroke : official journal of the International Stroke Society, 16(9), 1031-1038. https://doi.org/10.1177/1747493021991961
Koemans, E A, et al. "Striped occipital cortex and intragyral hemorrhage: Novel magnetic resonance imaging markers for cerebral amyloid angiopathy." International journal of stroke : official journal of the International Stroke Society vol. 16,9 (2021): 1031-1038. doi: https://doi.org/10.1177/1747493021991961
Koemans EA, Voigt S, Rasing I, Jolink W, van Harten TW, van der Grond J, van Rooden S, Schreuder F, Freeze WM, van Buchem MA, van Zwet EW, van Veluw SJ, Terwindt GM, van Osch M, Klijn C, van Walderveen M, Wermer M. Striped occipital cortex and intragyral hemorrhage: Novel magnetic resonance imaging markers for cerebral amyloid angiopathy. Int J Stroke. 2021 Dec;16(9):1031-1038. doi: 10.1177/1747493021991961. Epub 2021 Feb 03. PMID: 33535905.
Copy Download .nbib Format: NLM
Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?.

Journal of neurology, neurosurgery, and psychiatry

Hardy TA, Young S, Sy JS, Colley AF, Terwindt GM, Ferrari MD, Hayes MW, Hodgkinson S.
PMID: 28794152
J Neurol Neurosurg Psychiatry. 2017 Aug 09; doi: 10.1136/jnnp-2017-316142. Epub 2017 Aug 09.

No abstract available.

Cite
Hardy TA, Young S, Sy JS, et al. Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?. J Neurol Neurosurg Psychiatry. 2017;doi: 10.1136/jnnp-2017-316142.
Hardy, T. A., Young, S., Sy, J. S., Colley, A. F., Terwindt, G. M., Ferrari, M. D., Hayes, M. W., & Hodgkinson, S. (2017). Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?. Journal of neurology, neurosurgery, and psychiatry, . https://doi.org/10.1136/jnnp-2017-316142
Hardy, Todd A, et al. "Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?." Journal of neurology, neurosurgery, and psychiatry vol. (2017). doi: https://doi.org/10.1136/jnnp-2017-316142
Hardy TA, Young S, Sy JS, Colley AF, Terwindt GM, Ferrari MD, Hayes MW, Hodgkinson S. Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?. J Neurol Neurosurg Psychiatry. 2017 Aug 09; doi: 10.1136/jnnp-2017-316142. Epub 2017 Aug 09. PMID: 28794152.
Copy Download .nbib Format: NLM
Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.

The journal of headache and pain

Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas DD, Martelletti P.
PMID: 31122188
J Headache Pain. 2019 May 23;20(1):58. doi: 10.1186/s10194-019-0972-5.

AbstractFollowing publication of the original article [1], the authors notified us of some misreported data due to the publication of the EVOLVE-2 trial (Cephalalgia. 2018;38:1442-1454), which substantially changed the level of evidence of galcanezumab for the prevention of episodic...

Cite
Sacco S, Bendtsen L, Ashina M, et al. Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain. 2019;20(1):58doi: 10.1186/s10194-019-0972-5.
Sacco, S., Bendtsen, L., Ashina, M., Reuter, U., Terwindt, G., Mitsikostas, D. D., & Martelletti, P. (2019). Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. The journal of headache and pain, 20(1), 58. https://doi.org/10.1186/s10194-019-0972-5
Sacco, Simona, et al. "Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention." The journal of headache and pain vol. 20,1 (2019): 58. doi: https://doi.org/10.1186/s10194-019-0972-5
Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas DD, Martelletti P. Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain. 2019 May 23;20(1):58. doi: 10.1186/s10194-019-0972-5. PMID: 31122188; PMCID: PMC6734242.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 42 entries